Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}); Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography—Global Forecast to 2030
Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}); Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography—Global Forecast to 2030
According to the research report titled ‘Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets}), Astaxanthin Bulk Finished Products {Capsules, Tablets}); Application (Nutraceuticals, Aquaculture, Cosmetics, Food), and Geography—Global Forecast to 2030,’ in terms of value, the haematococcus pluvialis market is projected to reach $189.8 million by 2030, at a CAGR of 13.3% from 2023 to 2030, while in terms of volume, this market is projected to reach 1,369.9 tons by 2030, at a CAGR of 14.8% from 2023 to 2030. The report provides an in-depth analysis of the haematococcus pluvialis market across five major geographies, current market trends, recent developments, and the market size & forecast till 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by increasing demand for natural astaxanthin for nutraceuticals, growing natural food colorant’s demand, and increasing awareness for clean-label products. However, the high production cost is expected to restrain the growth of this market. The growing demand for natural astaxanthin and its use in poultry and aquaculture is expected to create market growth opportunities. However, the complex production process for haematococcus pluvialis is a major challenge for the players operating in this market.
Based on product, the haematococcus pluvialis market is mainly segmented into astaxanthin ingredients and astaxanthin bulk finished products. In 2023, the astaxanthin ingredients segment is expected to account for the largest share of the global haematococcus pluvialis market. The large market share of this segment is mainly attributed to the growing end-use applications of astaxanthin ingredients, rising awareness about preventive healthcare & nutraceuticals, rising demand for natural antioxidants, growing cosmetic & personal care markets, and government initiatives to support the aquaculture industry.
Based on application, the haematococcus pluvialis market is segmented into nutraceuticals, aquaculture and animal feed, cosmetics, food and beverages, and pharmaceuticals. In 2023, the nutraceuticals segment is expected to account for the largest share of the global haematococcus pluvialis market. The large market share of this segment is mainly attributed to the growth of this segment are the growing end-use applications of astaxanthin ingredients, rising awareness about preventive healthcare & nutraceuticals, rising demand for natural antioxidants, growing cosmetic & personal care markets, and government initiatives to support the aquaculture industry.
An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. Asia-Pacific is expected to witness significant growth during the forecast period, mainly due to increasing health consciousness, growing nutraceutical and F&B industries, increasing demand for personal care products, and high investments for algae production offer significant opportunities for various stakeholders in the Asia-Pacific region. Also, the growing adoption of haematococcus pluvialis-derived products is fueling the growth of the nutraceutical industry.
The key players operating in the haematococcus pluvialis market are E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), Plankton Australia Pty Limited (Australia), Shaanxi Rebecca Bio-Tech Co., Ltd (China), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), Yunnan Alphy Biotech Co.,Ltd (China), Beijing Gingko Group (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), AstaMAZ NZ LTD (New Zealand), FjordAlg AS (Norway), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), MC Biotech Sdn. Bhd. (Brunei Darussalam), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), Algae to Omega, LLC (U.S.), Shaivaa Algaetech LLP (India), and Astaxa GmbH (Germany).
Key Questions Answered in the Report- What is the value of revenue generated by the haematococcus pluvialis market?
At what rate is the global demand for haematococcus pluvialis projected to grow for the next 5-7 years?
What is the historical market size and growth rate for the haematococcus pluvialis market?
What are the major factors impacting the growth of this market at global and regional levels?
What are the major opportunities for existing players and new entrants in the market?
What impact does the current COVID-19 pandemic have on the haematococcus pluvialis market?
Which product and application segments create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the haematococcus pluvialis market?
Who are the major players in the haematococcus pluvialis market? What are their specific product offerings in this market?
What recent developments have taken place in the haematococcus pluvialis market? What impact have these strategic developments created on the market?
Scope of the Report:
Global Haematococcus Pluvialis Market, by ProductAstaxanthin Ingredients
Astaxanthin Oleoresin
Beadlets
Whole Biomass Powder
Water Dispersible Powder
Astaxanthin Bulk Finished Products
Capsules/Softgels
Tablets
Global Haematococcus Pluvialis Market, by ApplicationNutraceutical
Aquaculture and Animal Feed
Cosmetics
Food & Beverages
Pharmaceuticals
Global Haematococcus Pluvialis Market, by GeographyNorth America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Sweden
Spain
Russia
Netherlands
Denmark
Poland
Rest of Europe (RoE)
Asia-Pacific
China
Japan
India
Australia
South Korea
Vietnam
Rest of Asia-Pacific (RoAPAC)
Latin America
Brazil
Mexico
Argentina
Rest of Latin America (RoLATAM)
Middle East and Africa
Israel
Egypt
Saudi Arabia
South Africa
UAE
Rest of Middle East & Africa
Global Haematococcus Pluvialis Market - Report SummaryReport Metrics | Details |
---|
Years Considered | 2023 - 2030 |
Base Year | 2022 |
Forecast Period | 2023-2030 |
Page Count | 281 |
Units Referenced | Value (USD Thousand), Volume (Thousand Tons) |
Segments/Key Topics | Market by Product, Market by Application, Market by Geography |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) |
Key Companies Mentioned | E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), Plankton Australia Pty Limited (Australia), Shaanxi Rebecca Bio-Tech Co., Ltd (China), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), Yunnan Alphy Biotech Co.,Ltd (China), Beijing Gingko Group (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), AstaMAZ NZ LTD (New Zealand), FjordAlg AS (Norway), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), MC Biotech Sdn. Bhd. (Brunei Darussalam), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), Algae to Omega, LLC (U.S.), Shaivaa Algaetech LLP (India), and Astaxa GmbH (Germany).Australia Pty Limited (Australia), Hangzhou Ouqi Food Co., Ltd. (China), and Shaanxi Rebecca Bio-Tech Co., Ltd (China) |
FAQs About the Report
What is the Focus of Haematococcus Pluvialis Market Report?This report provides detailed market insights, size, and forecasts of the global haematococcus pluvialis market segmented by product, application, and geography. In this study, we have considered the revenue of haematococcus pluvialis biomass in the form of astaxanthin ingredients and bulk finished products. The application of these products includes nutraceuticals, aquaculture and animal feed, cosmetics, food & beverages, and pharmaceuticals.
What is the current revenue value generated by the global Haematococcus Pluvialis market? At what rate is the global Haematococcus Pluvialis market projected to grow in the next 5–7 years?The haematococcus pluvialis market is projected to reach $189.8 million by 2030, at a CAGR of 13.3% during the forecast period.
Which is the High-growth Application Segment of the Haematococcus Pluvialis Market?Based on the application, the nutraceutical segment is expected to grow the fastest during the forecast period.
What are the Major Drivers for this Market?Some of the key drivers of this market are increasing demand for natural astaxanthin for nutraceuticals, growing demand for natural food colorants, and increasing awareness of clean-label products
What is the Major Restraint for the Global Haematococcus Pluvialis Market?The key restraint of this market is high production cost
Who are the Major Players Operating in the Global Haematococcus Pluvialis Market?The key players operating in the global haematococcus pluvialis market are E.I.D. - Parry (India) Limited (A Subsidiary of M/S. Ambadi Investments Limited) (India), Cyanotech Corporation (U.S.), YUNNAN GREEN A BIOLOGICAL PROJECT CO., LTD. (Yunnan Spirin Biotechnology Co. Ltd) (China), Sun Chlorella Corporation (Japan), Roquette Klötze GmbH & Co. KG (Germany), Tianjin Norland Biotech Co., Ltd (China), Aliga Microalgae (Denmark), DAESANG Corporation (Korea), Plankton Australia Pty Limited (Australia), Shaanxi Rebecca Bio-Tech Co., Ltd (China), BlueBioTech Group (Germany), Algatechnologies Ltd. (A Part of Solabia Group) (Israel), AstaReal Group (Japan), Yunnan Alphy Biotech Co.,Ltd (China), Beijing Gingko Group (BGG) (U.S.), FENCHEM (China), PIVEG, Inc. (U.S.), Algamo s.r.o. (Czech Republic), Algalíf Iceland ehf. (Part of Sana Pharma Industries) (Iceland), Atacama Bio Natural Products S.A. (Chile), BDI BioLife Science GmbH (Austria), AstaMAZ NZ LTD (New Zealand), FjordAlg AS (Norway), Sea & Sun Organic GmbH (Subsidiary of Sea & Sun Technology GmbH) (Germany), MC Biotech Sdn. Bhd. (Brunei Darussalam), Pond Technologies Inc. (Canada), Algicel, Biotecnologia e Investigação, Lda (Portugal), Algae to Omega, LLC (U.S.), Shaivaa Algaetech LLP (India), and Astaxa GmbH (Germany).
Which is the fastest-growing region in the market?Asia-Pacific is expected to witness significant growth during the forecast period, mainly due to increasing health consciousness, growing nutraceutical and F&B industries, increasing demand for personal care products, and high investments in algae production.